Miller-Meeks Introduces the Orally Taken Contraception Act of 2023

WASHINGTON, D.C. – U.S. Representatives Mariannette Miller-Meeks (Iowa-01), Jen Kiggans (Va.-02), Lori Chavez-DeRemer (Ore.-05), María Elvira Salazar (Fla.-27), Nicole Malliotakis (N.Y.-11), Marjorie Taylor Greene (Ga.-14), Young Kim (Calif.-40), Diana Harshbarger (Tenn.-01), and Stephanie Bice (Okla.-05) introduced the Orally Taken Contraception Act of 2023 (OTC Act of 2023), legislation that would require the FDA to send guidance to manufacturers on how to submit successful over-the-counter applications for oral contraceptives…

“Women across the country, and especially rural women, face continued government and economic barriers when it comes to accessing birth control. At the R Street Institute, we have a free market approach to contraceptive access which boasts that increasing access and reducing government barriers will lead to reduced prices across the board. For that reason, we are thrilled to support and endorse the OTC Act which will help streamline the process to make regular oral contraceptives over the counter. Congresswoman Miller-Meeks’ common sense approach background as a doctor, nurse, mother, and legislator gives her the platform to not only lead on this issue but deliver on it,” said Anthony Lamorena, Senior Federal Affairs Manager at the R Street Institute...

Background:

The Orally Taken Contraception Act of 2023 requires the FDA to send guidance to manufacturers on how to submit successful over-the-counter applications for oral contraceptives, expands access to over-the-counter contraceptives by increasing regulatory clarity to promote competition, and provides women with options for preventative health care.